ILEX
ILEX is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €6.21M and a net result of €-106k. Equity is growing by ~33.9% per year across the filed fiscal years. Its solvency ranks better than 89% of 1399 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €6.21M |
| Net result | €-106k |
| Better than sector | 89% |
| Active | 5 yrs |
Mixed profile: strong on solvency, weaker on health.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 89.9% | 37.2% | |
| Net result | €-106k | €46k | |
| Equity | €6.21M | €361k | |
| Gross operating margin | €-47k | €66k | |
| Total assets | €6.90M | €1.40M |
| Fiscal year | 2024 |
|---|---|
| Revenue | n/a |
| EBITDA | n/a |
| Net profit | €-106k |
| Cash flow | n/a |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €6.90M |
| Equity | €6.21M |
| Debt | €694k |
| of which ≤ 1y | €683k |
| of which > 1y | - |
| Working capital | n/a |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | n/a |
| Quick ratio | n/a |
| Working capital ratio | n/a |
| Solvency | 89.9% |
| Debt / equity | n/a |
| Long-term debt ratio | n/a |
| Interest coverage | n/a |
| Gross margin | n/a |
| Net margin | n/a |
| ROA | -1.5% |
| ROE | -1.7% |
| EBITDA margin | n/a |
| Days sales outstanding | n/a |
| Days payable outstanding | n/a |
| Inventory turnover | n/a |
| Days inventory (DSI) | n/a |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €6.90M |
| Fixed assets | 21/28 | €4.66M |
| Formation expenses | 20 | €4k |
| Financial fixed assets | 28 | €4.66M |
| Current assets | 29/58 | €2.24M |
| Amounts receivable within one year | 40/41 | €1.99M |
| Cash & bank | 54/58 | €195k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €6.90M |
| Equity | 10/15 | €6.21M |
| Contributions / capital | 10/11 | €6.42M |
| Accumulated profits (losses) | 14 | €-211k |
| Amounts payable | 17/49 | €694k |
| Amounts payable within one year | 42/48 | €683k |
| Trade debts payable within one year | 44 | €27k |
| Income statement | ||
| Gross operating margin | 9900 | €-47k |
| Operating result | 9901 | €-50k |
| Financial income | 75 | €58k |
| Financial charges | 65 | €115k |
| Result before taxes | 9903 | €-106k |
| Net result for the period | 9904 | €-106k |
| Result to be appropriated | 9905 | €-106k |
| NACE primary | Financial services(64210) |
| Legal form | Public limited company(014) |
| Incorporation | 09-06-2021 |
| Status | Active |
| Postal code | 8880 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36018A0282/00D000 | Flanders | 7,117 m² | 1 · 202 m² | 9.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-07-2025 Capital increase of €2,350,000 to €8,766,660.25
- €6.416.660,25 → €8.766.660,25
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8766660.25,
"delta_eur": 2350000.0,
"before_eur": 6416660.25,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 719,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 2350000.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 2350000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Andreas LAGA",
"firm_city": null,
"firm_name": null,
"office_city": "Izegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-03",
"filing_date": "2025-07-01",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2025-06-27",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-06-27"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0769.522.477",
"name_full": "ILEX",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Franky Houtteman",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van de akte dd. 27 juni 2025, met aangehechte volmachten",
"geco\u00F6rdineerde statuten met lijst publicatiedata"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "NICAT INVEST",
"role": "niet-statutaire bestuurder",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 3414,
"class_name": "Gewone Aandelen",
"capital_share_eur": 8766660.25,
"voting_rights_per_share": 1.0
}
]
}18-10-2024 Capital increase of €1,416,665.25 to €6,416,660.25
- €4.999.995 → €6.416.660,25
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6416660.25,
"delta_eur": 1416665.25,
"before_eur": 4999995.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 595,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 1416665.25,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Andreas LAGA",
"firm_city": null,
"firm_name": null,
"office_city": "Izegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-10-18",
"filing_date": "2024-10-16",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-10-09",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-10-09"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0769.522.477",
"name_full": "ILEX",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van de akte dd. 9 oktober 2024",
"geco\u00F6rdineerde statuten met lijst publicatiedata"
],
"shareholders_after": [
{
"kbo": "0764.534.895",
"pct": null,
"kind": "org",
"name": "Hestia MIF\u00B2",
"role": "aandeelhouder",
"n_shares": 2695,
"share_class": null
}
],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ILEX |